Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

NCT03531905 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

NCT02585778 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

NCT00251680 ·Status: COMPLETED ·Phase: PHASE3

Necessity for Lipid Lowering Therapy in Type 2 Diabetes Patients

NCT00639080 ·Status: COMPLETED

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia

NCT05355402 ·Status: COMPLETED ·Phase: PHASE2

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

NCT05610280 ·Status: COMPLETED ·Phase: PHASE3

Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)

NCT01436253 ·Status: COMPLETED

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion

NCT04314167 ·Status: TERMINATED ·Phase: NA

Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

NCT05905068 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome

NCT00659321 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic

NCT06109831 ·Status: COMPLETED ·Phase: PHASE2

Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins

NCT00953498 ·Status: COMPLETED ·Phase: PHASE4

A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

NCT07229937 ·Status: RECRUITING ·Phase: PHASE2

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia

NCT00304993 ·Status: COMPLETED ·Phase: PHASE4

Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

NCT01211847 ·Status: COMPLETED ·Phase: PHASE2

Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy

NCT02926027 ·Status: COMPLETED ·Phase: PHASE4

To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

NCT00271817 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia

NCT04239950 ·Status: COMPLETED ·Phase: PHASE3

the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C

NCT06132360 ·Status: COMPLETED ·Phase: PHASE1

An Experimental Medicine Study to Evaluate Serum Biomarkers of Lipid Metabolism

NCT00847782 ·Status: COMPLETED ·Phase: NA

Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)

NCT04606602 ·Status: COMPLETED ·Phase: PHASE1

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

NCT05365425 ·Status: RECRUITING ·Phase: PHASE4

Study to Test GSK256073 in Patients With Dyslipidemia

NCT00903617 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers

NCT06758661 ·Status: COMPLETED ·Phase: PHASE1

Effects of Nutraceutical Therapies on Endothelial Function, Platelet Aggregation, and Coronary Flow Reserve

NCT02969070 ·Status: COMPLETED ·Phase: NA